Belgium

Excessive pricing practices in the pharmaceutical sector – NCAs’ scrutiny continues

Nele De Backer

Last week, the Belgian and Italian consumer associations Test Aankoop/Test Achats and Altroconsumo filed complaints with their respective national competition authorities, alleging that the pharmaceutical group Biogen is abusing its dominant position by charging excessively high prices for the medicine Spinraza, which it has the exclusive right to market as an orphan drug until 2029. Read More

Belgium: New developments point at possibly imminent changes in (online) pharmacy market

Tine Carmeliet

In Belgium, two recent events have drawn attention to the (online) pharmacy market. First, on 28 May 2019, the Competition Court of the Belgian Competition Authority (BCA) imposed a fine of EUR 1 million on the Belgian Order of Pharmacists for the use of anti-competitive practices aimed at excluding the MediCare-Market group, an association of (para)-pharmacies Read More

Belgium amends procedure for notification of implants and certain invasive medical devices

Kaat Van Delm

On 1 June 2019, a new Royal Decree (dated 7 April 2019) altering the notification procedure for implants and certain invasive medical devices for long-term use entered into force. Previously, the Belgian Sickness and Invalidity Institute (RIZIV/INAMI) needed to be notified if implants and certain invasive medical devices were used long-term, while distributors of medical Read More

Belgium amends procedure for notification of implants and certain invasive medical devices

Kaat Van Delm

On 7 April 2019, a law altering the notification procedure for implants and certain invasive medical devices for long-term use was adopted. Previously, the Belgian Sickness and Invalidity Institute (INAMI) needed to be notified if implants and certain invasive medical devices were used long-term, while distributors of medical devices were required to register with the Read More

Belgium modifies legislation regarding unavailability of medicines

Kaat Van Delm

On 28 March 2019, the Chamber of Representatives approved a law which changes the rules applicable to shortages of medicines. This law will amend the Law of 25 March 1964 concerning medicinal products. So far, only the draft bill has been made available, as the changes have not yet been published in the Belgian Official Gazette. Read More